Vaxart
VXRT
#9405
Rank
A$0.12 B
Marketcap
A$0.54
Share price
-2.84%
Change (1 day)
-45.38%
Change (1 year)

Vaxart (VXRT) - Cash on Hand

Cash on Hand as of June 2025 : A$39.44 Million

According to Vaxart's latest financial reports the company has A$39.44 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vaxart - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$83.15 M42.66%
2023-12-31A$58.29 M-58.56%
2022-12-31A$0.14 B-38.75%
2021-12-31A$0.22 B39.18%
2020-12-31A$0.16 B754.06%
2019-12-31A$19.31 M18.8%
2018-12-31A$16.26 M
2017-06-30A$50.27 M-45.73%
2016-06-30A$92.63 M23.74%
2015-06-30A$74.86 M-13.6%
2014-06-30A$86.64 M18.41%
2013-06-30A$73.17 M
2011-12-31A$94 M-11.72%
2010-12-31A$0.10 B-19.61%
2009-12-31A$0.13 B-28.29%
2008-12-31A$0.18 B-26.32%
2007-12-31A$0.25 B66.47%
2006-12-31A$0.15 B3.06%
2005-12-31A$0.14 B9.68%
2004-12-31A$0.13 B-14.44%
2003-12-31A$0.15 B69.59%
2002-12-31A$91.82 M-64.28%
2001-12-31A$0.25 B9148.83%
2000-12-31A$2.77 M126.6%
1999-12-31A$1.22 M-24.9%
1998-12-31A$1.63 M-68.71%
1997-12-31A$5.21 M-77.59%
1996-12-31A$23.28 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
A$3.33 M-91.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$0.19 M-99.50% Bahamas